Stock listing
A420P3 Stock Price, News, Filings & Events — Definium Therapeutics, Inc.
Selected listing: A420P3 · LS · EUR · DE
This page tracks Definium Therapeutics, Inc.'s A420P3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A420P3:LS. A420P3:LS is the stock-level entry point for investors researching Definium Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Definium Therapeutics, Inc. (Ticker: DFTX) is a public company based in the United States, with a market capitalization of approximately $5.73 billion. The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, Definium Therapeutics is listed on the American market, providing investors with opportunities to engage with its growth and advancements in the healthcare sector.
- Ticker
- A420P3:LS
- Asset type
- Stock
- Market cap
- $6.03B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Definium Therapeutics, Inc. A420P3:LS stock context
This page tracks Definium Therapeutics, Inc.'s A420P3:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A420P3:LS. A420P3:LS is the stock-level entry point for investors researching Definium Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Definium Therapeutics, Inc. (Ticker: DFTX) is a public company based in the United States, with a market capitalization of approximately $5.73 billion. The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, Definium Therapeutics is listed on the American market, providing investors with opportunities to engage with its growth and advancements in the healthcare sector.
Latest news from Definium Therapeutics, Inc.
Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder
August 12, 2026
Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Ca...
July 14, 2026
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Optio...
June 25, 2026
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
June 23, 2026
Definium Therapeutics, Inc. earnings calls
Research Definium Therapeutics, Inc.
Definium Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A420P3:LS.
Definium Therapeutics, Inc. company profile
View the public company page for Definium Therapeutics, Inc. on 6ix.
Definium Therapeutics, Inc. news
Read company news and market updates connected to Definium Therapeutics, Inc..
Definium Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Definium Therapeutics, Inc..
Alternate listings
DFTX:NASDAQ
US · USD
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:GETTEX
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
DFTX:BOATS
US · USD
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:TRADEGATE
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
A420P3:LSX
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:FWB
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:SWB
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:MUN
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.
MMQ0:DUS
DE · EUR
Alternate listing for Definium Therapeutics, Inc.; the primary context on this page is A420P3:LS.